Skip to main content

An official website of the United States government

You have 2 new alerts

Notice of Intent to Sole Source – Therakos, Inc.

General Information

  • Contract Opportunity Type: Special Notice (Original)
  • Original Published Date: Jul 08, 2024 03:45 pm EDT
  • Original Response Date: Jul 23, 2024 09:00 am EDT
  • Inactive Policy: 15 days after response date
  • Original Inactive Date: Aug 07, 2024
  • Initiative:
    • None

Classification

  • Original Set Aside:
  • Product Service Code:
  • NAICS Code:
  • Place of Performance:
    Bethesda , MD
    USA

Description

This urgent acquisition is for Uvadex (methoxsalen) Sterile Solution for the National Institutes of Health (NIH) Clinical Center (CC) Central Pharmacy.

•            Product Service Code: 6515 – Surgical and Medical Equipment and Supplies

•            NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing

•            Place of Performance: Bethesda, MD 20892 USA

POTS: 24-008555

Description:

This is a notice of intent, not a request for a quotation.  A solicitation document will not be issued and quotations will not be requested.

The National Institutes of Health (NIH) intends to award a fixed price purchase order to Therakos, Inc., located at 675 James S McDonnell Blvd, Hazelwood, MO 63042, on a firm fixed price sole source award basis to provide Uvadex to the National Institutes of Health.

Below is a description of the item(s):

Description: Uvadex (Methoxsalen) 20 mcg/mL; Sterile Solution

Catalog #: 21612

Units: Carton

Qty: 2

The proposed vendor, Therakos, Inc, is able to provide this urgent requirement for pharmaceutical supplies within the required time to the NIH CC Central Pharmacy.

This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available.  Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.

Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.

Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by July 23, 2024 at 9am EST.

Contact Information

Primary Point of Contact





Secondary Point of Contact





History